COVID-19 outbreak: Alfasigma donates over 100.000 euros to Romanian Hospitals
Innovation Pharmaceuticals Announces License Agreement with Alfasigma S.p.A. for the Development and Commercialization of Brilacidin in Ulcerative Proctitis/Ulc...
Alfasigma USA Acquires Zelnorm™
Alfasigma SpA – Corporate announcement
Alfasigma expands its footprint in the U.S. through the acquisition of Pamlab from Nestle health science
Alfasigma is born the new italian pharmaceutical entity with strong international presence
Launch of the industrial Partnership in the Pharma Business between Alfa Wassermann and Sigma-Tau: setting up a leading italian pharmaceutical Group